PharmX Technologies Limited

ASX:PHX Stock Report

Market Cap: AU$80.9m

PharmX Technologies Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Tom Culver

Chief executive officer

AU$513.9k

Total compensation

CEO salary percentage66.74%
CEO tenure2yrs
CEO ownership0.05%
Management average tenure2yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

Feb 12
What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

Jul 12
A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

May 11
At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

Nov 12
Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Apr 29
At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Mar 02
Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Dec 13
Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

CEO Compensation Analysis

How has Tom Culver's remuneration changed compared to PharmX Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025AU$514kAU$343k

-AU$264k

Mar 31 2025n/an/a

-AU$125k

Dec 31 2024n/an/a

AU$14k

Sep 30 2024n/an/a

AU$55k

Jun 30 2024AU$219kAU$191k

AU$95k

Compensation vs Market: Tom's total compensation ($USD335.90K) is about average for companies of similar size in the Australian market ($USD293.30K).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.

CEO

Tom Culver

2yrs
Tenure
AU$513,891
Compensation

Mr. Thomas Culver, also known as Tom, served as Head of Wealth & Crypto Services at Stakk Limited (formerly known as Douugh Limited) since January 2021. Mr. Culver is Goodments Founder & CEO. Mr. Culver is...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Culver
Chief Executive Officer2yrsAU$513.89k0.048%
A$ 38.6k
Zoe Hillier
Chief Financial Officer4.3yrsAU$157.50k0.10%
A$ 84.4k
Andrew Jonathan Newbery
COO & Executive Directorno dataAU$302.55k0.29%
A$ 231.3k
Christopher Fernandes
Company Secretary1yrno datano data
2.0yrs
Average Tenure

Experienced Management: PHX's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrew Jonathan Newbery
COO & Executive Director5.8yrsAU$302.55k0.29%
A$ 231.3k
Jayne Shaw
Independent Non-Executive Director5.1yrsAU$98.12k0.46%
A$ 375.4k
Philip England
Non-Executive Chairman6yrsAU$396.52k4.5%
A$ 3.6m
Alexander Mellis
Non-Executive Directorless than a yearAU$75.65kno data
5.4yrs
Average Tenure

Experienced Board: PHX's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/15 22:35
End of Day Share Price 2025/11/14 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PharmX Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.